Atıf İçin Kopyala
Yurdaydin C., Keskin O., Kalkan C., Karakaya F., Caliskan A., Kabacam G., ...Daha Fazla
JOURNAL OF INFECTIOUS DISEASES, cilt.217, sa.8, ss.1184-1192, 2018 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
217
Sayı:
8
-
Basım Tarihi:
2018
-
Doi Numarası:
10.1093/infdis/jix656
-
Dergi Adı:
JOURNAL OF INFECTIOUS DISEASES
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.1184-1192
-
Anahtar Kelimeler:
Hepatitis B, interferon treatment, hepatocellular carcinoma, liver-related mortality, HBsAg clearance, HIV-INFECTED PATIENTS, HDV RNA RELAPSE, PEGYLATED INTERFERON-ALPHA-2B, COINFECTED PATIENTS, ALPHA THERAPY, VIRUS, TENOFOVIR, EFFICACY, REPLICATION, COMBINATION
-
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli:
Hayır
Özet
Background. Interferon is the only treatment option in chronic delta hepatitis (CDH). A CDH database (333 patients, 161 with interferon treatment history) was analyzed for effects of treatment duration on virologic response and clinical outcomes.